Skip to main content

Published

Background incidence rates and observed-to-expected ratios of adverse events of special interest after covid-19 mRNA vaccination during pregnancy in France: a nationwide population-based study.
Escolano S. The Lancet Regional Health – Europe 2026;:https://doi.org/10.1016/j.lanepe.2026.101630.
[Our objective was to assess the risk of adverse events of special interest (AESI) after mRNA vaccination during pregnancy using the French National Health Data System. This work did not evidence any safety signal after mRNA vaccination against COVID-19 for AESI during pregnancy. It contributes to the growing body of evidence regarding its safety.]
Freely available online

Age Groups
Adults
Conditions and Lifestyle Factors
Coronavirus Infections
Pregnancy and Child Birth
Settings
Population Health
Staff Groups
Immunisation
Public Health Doctor
Public Health Specialist